![]() Storm Therapeutics Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer. | ![]() Oxford Biodynamics Oxford BioDynamics Plc, a biotechnology company, discovers and develops novel biomarkers. | ![]() Cambridge Epigenetix Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw. | ||
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2007 | Founding Date 2012 |
Type | Type Private | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Norwich, GB HQ Norwich, GB | Locations Cambridge, GB HQ Greater London, GB | Locations Oxford, GB HQ George Town, MY Halesowen, GB London, GB Oxford, GB Stratford Upon Avon, GB New York, US | Locations Little Chesterford, GB HQ Wilmslow, GB |
Employees | Employees 572% decrease | Employees 327% increase | Employees 51 | Employees 1121% decrease |
Financial | ||||
Net income | Net income N/A | Net income N/A | Net income (£11.2m) (FY, 2025) | Net income (£86.2k) (FY, 2012) |
Funding | ||||
Latest funding round | Latest funding round $ 1.4m (over 7 years ago) | Latest funding round $ 5.4m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 30m (about 8 years ago) |
Total funding raised | Total funding raised $ 1.5m | Total funding raised $ 21.4m | Total funding raised N/A | Total funding raised $ 56.5m |

Storm Therapeutics discovers and develops small molecule drugs that target RNA-modifying enzymes, for treatment of cancer.
View company
Oxford BioDynamics Plc, a biotechnology company, discovers and develops novel biomarkers.
View company
Cambridge Epigenetix (also known as CEGX) is a bioscience company that uses epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
View company